<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13(1)</volume><submitter>Thome AD</submitter><funding>Ting Tsung and Wei Fong Chao Foundation in Houston, TX</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>Neuroinflammation is a hallmark of neurodegenerative disease and a significant component of the pathology of Alzheimer's disease (AD). Patients present with extensive microgliosis along with elevated pro-inflammatory signaling in the central nervous system and periphery. However, the role of peripheral myeloid cells in mediating and influencing AD pathogenesis remains unresolved.&lt;h4>Methods&lt;/h4>Peripheral myeloid cells were isolated from peripheral blood of patients with prodromal AD (n = 44), mild AD dementia (n = 25), moderate/severe AD dementia (n = 28), and age-matched controls (n = 54). Patients were evaluated in the clinic for AD severity and categorized using Clinical Dementia Rating (CDR) scale resulting in separation of patients into prodromal AD (CDR0.5) and ad</pubmed_abstract><journal>Molecular neurodegeneration</journal><pagination>61</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6233576</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Functional alterations of myeloid cells during the course of Alzheimer's disease.</pubmed_title><pmcid>PMC6233576</pmcid><pubmed_authors>Thonhoff JR</pubmed_authors><pubmed_authors>Thome AD</pubmed_authors><pubmed_authors>Zhao W</pubmed_authors><pubmed_authors>Appel SH</pubmed_authors><pubmed_authors>Masdeu JC</pubmed_authors><pubmed_authors>Wen S</pubmed_authors><pubmed_authors>Beers DR</pubmed_authors><pubmed_authors>Faridar A</pubmed_authors><pubmed_authors>Pascual B</pubmed_authors></additional><is_claimable>false</is_claimable><name>Functional alterations of myeloid cells during the course of Alzheimer's disease.</name><description>&lt;h4>Background&lt;/h4>Neuroinflammation is a hallmark of neurodegenerative disease and a significant component of the pathology of Alzheimer's disease (AD). Patients present with extensive microgliosis along with elevated pro-inflammatory signaling in the central nervous system and periphery. However, the role of peripheral myeloid cells in mediating and influencing AD pathogenesis remains unresolved.&lt;h4>Methods&lt;/h4>Peripheral myeloid cells were isolated from peripheral blood of patients with prodromal AD (n = 44), mild AD dementia (n = 25), moderate/severe AD dementia (n = 28), and age-matched controls (n = 54). Patients were evaluated in the clinic for AD severity and categorized using Clinical Dementia Rating (CDR) scale resulting in separation of patients into prodromal AD (CDR0.5) and ad</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Nov</publication><modification>2026-07-09T03:18:44.078Z</modification><creation>2019-03-27T00:08:25Z</creation></dates><accession>S-EPMC6233576</accession><cross_references><pubmed>30424785</pubmed><doi>10.1186/s13024-018-0293-1</doi></cross_references></HashMap>